Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.68
-0.02 (-0.11%)
Jan 29, 2026, 1:11 PM EST - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.91 billion as of January 29, 2026. Its market cap has increased by 87.09% in one year.
Market Cap
2.91B
Enterprise Value
2.24B
1-Year Change
87.09%
Ranking
Category
Stock Price
$17.68
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.91B, an increase of 268.07%. That is a compound annual growth rate of 27.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 2.91B | -9.51% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 3.16B |
| Beam Therapeutics | 3.05B |
| IDEAYA Biosciences | 3.02B |
| Erasca | 2.98B |
| Edgewise Therapeutics | 2.97B |
| Catalyst Pharmaceuticals | 2.95B |
| Disc Medicine | 2.93B |
| Adaptive Biotechnologies | 2.92B |